Literature DB >> 14766711

Effects of perioperative alpha1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma.

P Tauzin-Fin1, M Sesay, P Gosse, P Ballanger.   

Abstract

BACKGROUND: Laparoscopic surgery for phaeochromocytoma can cause excessive catechol amine release with severe hypertension and sinus tachycardia. i.v. calcium antagonists may be used to prevent increases in blood pressure during phaeochromocytoma resection. We investigated the effects of perioperative alpha(1) adrenergic block with urapidil on intraoperative haemodynamic events. The aim was to block the alpha(1) adrenergic receptors before any acute catecholamine release, to prevent any severe rise in blood pressure.
METHODS: Eighteen patients with a phaeochromocytoma received a continuous i.v. infusion of urapidil 10-15 mg h(-1) for 3 days before surgery and until the adrenal gland had been removed. Plasma catecholamine concentrations were measured before surgery, after induction of anaesthesia, at the end of pneumoperitoneal insufflation, during gland manipulation, after gland resection, and in the recovery room after extubation. Arterial pressure was recorded concomitantly. Hypertensive events were treated with boluses of nicardipine with or without esmolol.
RESULTS: All patients had the adrenal tumour removed without any severe rise in blood pressure or other complication. Creation of a pneumoperitoneum and adrenal gland manipulation induced significant catecholamine release associated with hypertension in 6 and 12 patients, respectively. No correlation was found between hypertensive events and plasma catecholamine levels suggesting alpha(1) receptor block with urapidil is efficacious.
CONCLUSIONS: Perioperative alpha(1) block using i.v. urapidil is a safe and efficient alternative during surgical management of phaeochromocytoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14766711     DOI: 10.1093/bja/aeh083

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  33 in total

1.  Liver resection for liver metastases from nondigestive endocrine cancer: extrahepatic disease burden defines outcome.

Authors:  Andreas Andreou; Antoine Brouquet; Kishore G S Bharathy; Nancy D Perrier; Eddie K Abdalla; Steven A Curley; Matthias Glanemann; Daniel Seehofer; Peter Neuhaus; Jean-Nicolas Vauthey; Thomas A Aloia
Journal:  Surgery       Date:  2012-02-04       Impact factor: 3.982

2.  Bi-spectral index guided closed-loop anaesthesia delivery system (CLADS) in pheochromocytoma.

Authors:  Harihar V Hegde; G D Puri; Bhupesh Kumar; Arunanshu Behera
Journal:  J Clin Monit Comput       Date:  2009-06-11       Impact factor: 2.502

3.  Antihypertensive therapy with nicardipine for patients with aortic disease is associated with more esmolol usage than urapidil.

Authors:  Kang-Song Wu; Jian-Cang Zhou; Hang-Yang Li; Dan-Yan Gu; Kong-Han Pan; Wei-Dong Li; Ying-Hong Hu
Journal:  J Thorac Dis       Date:  2014-12       Impact factor: 2.895

Review 4.  Factors affecting the haemodynamic behaviour of patients undergoing pheochromocytoma and paraganglioma removal: A review.

Authors:  Rashmi Ramachandran; Vimi Rewari
Journal:  Cardiovasc Endocrinol       Date:  2017-05-17

5.  Pheochromocytoma - update on disease management.

Authors:  Roland Därr; Jacques W M Lenders; Lorenz C Hofbauer; Bernd Naumann; Stefan R Bornstein; Graeme Eisenhofer
Journal:  Ther Adv Endocrinol Metab       Date:  2012-02       Impact factor: 3.565

6.  Urapidil in the preoperative treatment of pheochromocytomas: a safe and cost-effective method.

Authors:  Nils Habbe; Florian Ruger; Jorg Bojunga; Wolf Otto Bechstein; Katharina Holzer
Journal:  World J Surg       Date:  2013-05       Impact factor: 3.352

7.  Prospective study to compare peri-operative hemodynamic alterations following preparation for pheochromocytoma surgery by phenoxybenzamine or prazosin.

Authors:  Ritesh Agrawal; Saroj Kanta Mishra; Eesh Bhatia; Anjali Mishra; Gyan Chand; Gaurav Agarwal; Amit Agarwal; Ashok Kumar Verma
Journal:  World J Surg       Date:  2014-03       Impact factor: 3.352

Review 8.  [Pheochromocytoma - still a challenge].

Authors:  N Reisch; M K Walz; Z Erlic; H P H Neumann
Journal:  Internist (Berl)       Date:  2009-01       Impact factor: 0.743

Review 9.  Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management.

Authors:  Graeme Eisenhofer; Graham Rivers; Alejandro L Rosas; Zena Quezado; William M Manger; Karel Pacak
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

10.  Perioperative Management of Severe Hypertension during Laparoscopic Surgery for Pheochromocytoma.

Authors:  Mehmet Ali Erdoğan; Muharrem Uçar; Ahmet Selim Özkan; Ülkü Özgül; Mahmut Durmuş
Journal:  Turk J Anaesthesiol Reanim       Date:  2016-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.